Ultragenyx Pharmaceutical | RARE - Aktywa





Aktywa Zmiana Data
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
BioCryst Pharmaceuticals USD 591.07M 33.22M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Immunic USD 189.74M 165.69M 2026-03
Insmed USD 2.23B 123.49M 2026-09
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Kyowa Hakko Kirin JPY 1.09T 42.56B 2026-09
MacroGenics USD 345.41M 127.54M 2026-06
Moderna USD 13.47B 2.51B 2026-09
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09